Passez à l'illimité avec Magzter GOLD

Passez à l'illimité avec Magzter GOLD

Obtenez un accès illimité à plus de 9 000 magazines, journaux et articles Premium pour seulement

$149.99
 
$74.99/Année

Essayer OR - Gratuit

‘We may look at scaling to 50 per cent growth in the next financial year'

Express Pharma

|

January 16-31, 2020

Manish Jain, Managing Director of Cilicant Chem, a company that provides solutions to protect highly moisture-sensitive products from the harmful effects of moisture or humidity for the desiccant market, discusses the company's growth strategy with Akanki Sharma

- Akanki Sharma

‘We may look at scaling to 50 per cent growth in the next financial year'

What was the need to come up with Cilicant Chem?

Medicine spending in India is projected to grow nine to 12 per cent over the next five years, leading India to become one of the top 10 countries in terms of medicine spending. Pharma is amongst few industries which understand the criticality of having the right active packaging in the formulation of the product’s shelf life. Selection of active packaging is thus based upon many stability studies and trials.

Given this scenario, the active packaging in India, primarily has been coming from multi-national players, when India is definitely poised to manufacture the same international standard and quality indigenously.

Cilicant Chem was born out of that passion - the need for an indigenous source which will manufacture the right quality of active packaging to protect the products from degrading effects of moisture and oxygen.

Tell us about the solutions you offer to the pharma industry and other stakeholders.

Our products CILICANTFG desiccants sachets and canisters, and CILICANT oxygen absorbers have been specially designed for usage in primary packaging of pharmaceutical products, medical devices, diagnostic kits and food products. It adheres to the international quality standard and meets the requirement of US Food and Drug Administration (USFDA)standards with respect to Type III DMF (Drug Master File). Hence, it is completely safe for direct food contact in accordance with the Federal Food, Drug and Cosmetic Act requirement of 21 CFR. We have an array of desiccant solutions which ensures protection from the harmful effects of moisture and oxygen and provides the much required extended shelf life. The other industries include nutraceutical, medical devices, processed food, electronic equipment, etc.

How do you ensure the affordability and cost-efficiency of your solutions?

PLUS D'HISTOIRES DE Express Pharma

Express Pharma

Express Pharma

NEEDLES, PENS AND PRESSURE THE GLP-1 CHALLENGE

As GLP-1 therapies transform diabetes and obesity care, demand for prefilled pens and injectors is soaring. Pharma-device collaborations, analytical innovation, and sustainable design will be key to tackle the growing device bottleneck

time to read

7 mins

November 2025

Express Pharma

Express Pharma

Unified standards and smarter design are key to unlocking next-generation HVAC performance

Current HVAC design relies on a diverse, and sometimes confusing, array of guidelines issued by regulatory bodies such as WHO, EU GMP, ISO 14644, ISPE Baseline, and ASHRAE/ISHRAE.

time to read

2 mins

November 2025

Express Pharma

Express Pharma

Kyasanur Forest Disease - How far is a regulatory approved vaccine?

Dr Priyabrata Pattnaik, Former Deputy MD, Indian Immunologicals, informs about the Kyasanur Forest Disease (KFD), a zoonotic viral hemorrhagic fever endemic to parts of India, particularly along the Western Ghats and discusses the current status of developing a regulatory-approved KFD vaccine in India

time to read

3 mins

November 2025

Express Pharma

Express Pharma

India's biopharma industry charts the road from biosimilars to innovation

Express Pharma hosted the maiden Biopharma Leadership Conclave 2025 and brought together industry leaders to discuss how India can move from being the world's leading producer of generics and biosimilars to becoming a hub for innovative, affordable, and high-quality biologics and advanced therapies

time to read

4 mins

November 2025

Express Pharma

Express Pharma

Digital technologies are quietly transforming HVAC into an intelligent compliance partner

Over the last decade, HVAC standards in pharmaceutical manufacturing have undergone a quiet revolution.

time to read

2 mins

November 2025

Express Pharma

Express Pharma

Direct-to-Retail will increasingly complement traditional pharma distribution

Aqualab has crossed Rs 100 crore in just three years, what have been the key drivers behind this growth, and how does the brand plan to achieve the Rs 250 crore target by FY25-26?Aqualab's journey to Rs 100 crore within three years reflects the strength of a simple yet powerful principle, accessibility through proximity. Our growth has been anchored in three areas: a high-velocity retail network that prioritises last-mile availability, a well-diversified therapeutic portfolio spanning acute and chronic segments, and a strong focus on brand trust built through consistent product quality.

time to read

3 mins

November 2025

Express Pharma

Express Pharma

Guaranteeing continuity of medicine supply through AI innovation

Hari Kiran Chereddi highlights how AI is transforming pharma supply chains to ensure uninterrupted medicine availability

time to read

2 mins

November 2025

Express Pharma

PROSOLV® 730: Directly compressible carrier for lipophilic ingredients

Nearly 90 % of molecules in the discovery pipeline and 40 % of drugs with market approval are poorly water soluble. Poor aqueous solubility can lead to low bioavailability resulting in insufficient plasma levels. Oil-based preparations of these APIs, as well as oily APIs in general, present challenges in terms of solid dosage form manufacturing. PROSOLV® 730 was designed to provide a solution to the formulation of BCS class II and IV APIs. It enables the formulation of lipidic APIs or API-loaded lipid systems by facilitating the adsorption of oil, creating a free-flowing, compactible system that can be further formulated. PROSOLV® 730 is a co-processed, high-functionality excipient comprising MCC SILICA COPOVIDONE

time to read

2 mins

November 2025

Express Pharma

Express Pharma

Ensuring Clean Room Integrity with Prime Clean Reset High-Speed Doors: Minimizing Air Permeability and Leakages

High-speed doors for clean rooms are specialized industrial doors essential for maintaining controlled environments. These doors are engineered to be airtight, creating a reliable barrier between different areas of a facility. Their design ensures durability and minimal maintenance, reducing the frequency of repairs and replacements.

time to read

2 mins

November 2025

Express Pharma

Express Pharma

Reimagining cold chain: How IoT secures every pharma mile

Swarup Bose, Co-founder and CEO, Celcius Logistics points out that as the demand for temperature-sensitive medicines surges, maintaining an unbroken cold chain has never been more critical. IoT is emerging as the game-changer that ensures every vial and vaccine arrives potent, safe, and on time

time to read

3 mins

November 2025

Translate

Share

-
+

Change font size